Product · #17 of 27 · hot flashes (single active)
AZO Menopause Relief Daytime Gummies
Gummy from AZO, made by i-Health (dsm-firmenich), inferred. Daily serving: 1 gummy (2 g added sugar).
Last updated · Price and ratings checked Nov 19, 2026
In short: AZO Menopause Relief Daytime Gummies scores 48.6/100 in our ranking (#17 of 27). It costs $0.68 a day at the regular price. Evidence: genistein 30 mg; best ingredient grade B- (Soy isoflavones & genistein). No NSF registry listing was confirmed.
Pros
- Low cost: $0.68 a day at the label dose.
Cons
- No NSF registry listing confirmed.
- Few Amazon ratings so far (74).
Flags
None found
Score breakdown
Full label: what's in it
| Ingredient (as labeled) | Per day | Evidence page |
|---|---|---|
| Genistein | 30 mg | Soy isoflavones & genistein B- |
Genistein 30 mg. ConsumerLab's public summary cites at least 15 mg of genistein as an amount linked to effects; the main soy meta-analysis used a median of 54 mg of isoflavones.
Evidence
Our evidence score: 24/40, because: genistein 30 mg.
Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.
Ingredient evidence
- Soy isoflavones & genistein B- (30 mg here)
Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials. The Menopause Society 2023: Not recommended (Level II) – mixed evidence.
Studies
Studies on its ingredients (6)
-
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.
- Who
- 351 women aged 45–55
- Dose
- black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
- Duration
- 12 months
- Result
- No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
- Funding
- US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic
-
Phytoestrogens for menopausal vasomotor symptoms.
An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.
- Who
- 43 RCTs, 4,364 women
- Dose
- various phytoestrogens
- Duration
- various
- Result
- No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
- Funding
- Cochrane review (independent). Independent / academic
-
Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
Pooling 17 trials, soy isoflavone supplements (about 54 mg a day) cut hot-flash frequency by about a fifth more than placebo. Products higher in genistein worked better. Results varied widely between studies.
- Who
- 17 RCTs in meta-analysis
- Dose
- median 54 mg isoflavones/day
- Duration
- 6 weeks–12 months
- Result
- Hot-flash frequency -20.6% and severity -26.2% vs placebo; >18.8 mg genistein about twice as effective.
- Funding
- Academic (Japan/US); funding not stated in abstract. Funding not stated
-
Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.
A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.
- Who
- 62 studies, 6,653 women
- Dose
- phytoestrogens and other plant therapies
- Duration
- various
- Result
- Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
- Funding
- Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked
-
Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Italian women took high-dose soy isoflavones (150 mg a day) or placebo for 5 years. A small number on soy developed thickening of the womb lining (3.4% vs 0%), so long-term high doses deserve caution.
- Who
- 376 women with intact uterus
- Dose
- soy isoflavones 150 mg/day
- Duration
- 5 years
- Result
- Endometrial hyperplasia in 3.37% on soy vs 0% placebo; no cancers.
- Funding
- Not stated in abstract. Funding not stated
-
Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.
Studies following women with breast cancer found eating soy was linked to lower recurrence, not higher. These looked at soy food, not concentrated supplements.
- Who
- 12 cohort studies, 37,275 breast-cancer patients
- Dose
- dietary soy/isoflavone intake
- Duration
- observational
- Result
- Pre- and post-diagnosis soy intake associated with lower recurrence; no harm signal.
- Funding
- Academic. Independent / academic
The Menopause Society's 2023 statement is in the study library.
Price
| Regular one-time price | $20.49 (30 units, 30 days at label dose) |
|---|---|
| Cost per day | $0.68 |
| Subscription | $18.44 (10% off) |
| Price notes | Amazon B0FCWBBK1C list $24.99 ($19.94 BF). Nighttime gummies: genistein 30 mg + melatonin 1 mg, $20.49. Daily Menopause Support + Vit D tablets: genistein 30 mg + D 25 mcg, $20.49. |
| In stock when checked | Yes |
| Checked | Nov 19, 2026 |
Ratings
Amazon: ★ 4.4 from 74 ratings on Amazon (checked Nov 19, 2026)
Brand site: ★ 4.5, 211 reviews on azoproducts.com (date unconfirmed Unverified). Brand-site reviews are moderated by the brand.
Star ratings reflect buyer satisfaction, not clinical effect.
Certifications and claims
Verified in a public registry
- No registry listing found.
Claims made by the brand
- “hormone-free” Brand claim
- “vegan” Brand claim
- “no preservatives” Brand claim
- “HSA-eligible” Brand claim
Registry check: NSF/ANSI 173 ('i-Health'): not found
Who's behind it
| Brand | AZO |
|---|---|
| Owner / company | i-Health, Inc. (AZO brand; the same company as Estroven, part of the dsm-firmenich group). Inferred from an Amazon brand-video credit and i-Health's ownership of AZO; not shown on the azoproducts.com page we read. Unverified |
| Founders | Not stated on the pages we read. |
| Where it's made | not stated. |
| Medical advisors named | None named on the pages we read. |
| Source | amazon.com |
Flags & safety
Legal, regulatory and quality flags
- ConsumerLab 'Menopause Supplements Review' (soy/red clover isoflavones, black cohosh, progesterone cream) last updated 2026-10-29; product results are members-only (not accessed). Public summary: ≥50 mg soy isoflavones or ≥15 mg genistein / 28 mg daidzein for effect; only 1/3–1/2 of women are equol producers. Past rounds found products with 30–59% of listed isoflavones and a black cohosh product with lead. consumerlab.com
Ingredient safety notes
- Soy isoflavones & genistein: Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH).
Not verified
- Brand owner (inferred as i-Health). Unverified
Sources
Talk to a clinician first
The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).
If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.